Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary.

Institute of Medicine (US).

Washington (DC): National Academies Press (US); 2012.

2.

A virtual national laboratory for reengineering clinical translational science.

Dilts DM, Rosenblum D, Trochim WM.

Sci Transl Med. 2012 Jan 25;4(118):118cm2. doi: 10.1126/scitranslmed.3002951.

3.

ResearchMatch: a national registry to recruit volunteers for clinical research.

Harris PA, Scott KW, Lebo L, Hassan N, Lightner C, Pulley J.

Acad Med. 2012 Jan;87(1):66-73. doi: 10.1097/ACM.0b013e31823ab7d2.

4.

Direct2Experts: a pilot national network to demonstrate interoperability among research-networking platforms.

Weber GM, Barnett W, Conlon M, Eichmann D, Kibbe W, Falk-Krzesinski H, Halaas M, Johnson L, Meeks E, Mitchell D, Schleyer T, Stallings S, Warden M, Kahlon M; Direct2Experts Collaboration.

J Am Med Inform Assoc. 2011 Dec;18 Suppl 1:i157-60. doi: 10.1136/amiajnl-2011-000200. Epub 2011 Oct 28.

5.

CTSA-IP: a solution to identifying and aggregating intellectual property across the NIH Clinical Translational Science Award (CTSA) consortium of biomedical research institutes.

Hazard M, Steele S, Wang D, Pearson T, Scheideler M, Dewhurst S.

Clin Transl Sci. 2011 Oct;4(5):328-31. doi: 10.1111/j.1752-8062.2011.00308.x. Review. Erratum in: Clin Transl Sci. 2012 Feb;5(1):112.

6.

Optimality, sample size, and power calculations for the sequential parallel comparison design.

Ivanova A, Qaqish B, Schoenfeld DA.

Stat Med. 2011 Oct 15;30(23):2793-803. doi: 10.1002/sim.4292. Epub 2011 Jul 29.

PMID:
21805484
7.

With strings.

[No authors listed]

Nature. 2011 Jul 20;475(7356):266. doi: 10.1038/475266a. No abstract available.

PMID:
21776038
8.

Reengineering translational science: the time is right.

Collins FS.

Sci Transl Med. 2011 Jul 6;3(90):90cm17. doi: 10.1126/scitranslmed.3002747.

9.

Leveraging crowdsourcing to facilitate the discovery of new medicines.

Norman TC, Bountra C, Edwards AM, Yamamoto KR, Friend SH.

Sci Transl Med. 2011 Jun 22;3(88):88mr1. doi: 10.1126/scitranslmed.3002678.

PMID:
21697527
10.

Mining for therapeutic gold.

Collins FS.

Nat Rev Drug Discov. 2011 Jun;10(6):397. doi: 10.1038/nrd3461.

11.

The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics.

Huang R, Southall N, Wang Y, Yasgar A, Shinn P, Jadhav A, Nguyen DT, Austin CP.

Sci Transl Med. 2011 Apr 27;3(80):80ps16. doi: 10.1126/scitranslmed.3001862.

12.

Developing the Sentinel System--a national resource for evidence development.

Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J, Platt R.

N Engl J Med. 2011 Feb 10;364(6):498-9. doi: 10.1056/NEJMp1014427. Epub 2011 Jan 12. No abstract available.

13.

Pfizer reaches out to academia--again.

Ratner M.

Nat Biotechnol. 2011 Jan;29(1):3-4. doi: 10.1038/nbt0111-3. No abstract available.

PMID:
21221077
14.

Patent watch: the patent cliff steepens.

Harrison C.

Nat Rev Drug Discov. 2011 Jan;10(1):12-3. doi: 10.1038/nrd3356. No abstract available.

PMID:
21193859
15.

Regulatory science: what it is and why we need it.

FitzGerald GA.

Clin Pharmacol Ther. 2011 Feb;89(2):291-4. doi: 10.1038/clpt.2010.276. Epub 2010 Dec 15. No abstract available.

PMID:
21160470
16.

Shattuck lecture. Innovation, regulation, and the FDA.

Hamburg MA.

N Engl J Med. 2010 Dec 2;363(23):2228-32. doi: 10.1056/NEJMsa1007467. No abstract available.

PMID:
21121835
17.

Achieving a nationwide learning health system.

Friedman CP, Wong AK, Blumenthal D.

Sci Transl Med. 2010 Nov 10;2(57):57cm29. doi: 10.1126/scitranslmed.3001456.

PMID:
21068440
18.

Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.

Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C, Welebob E, Scarnecchia T, Woodcock J.

Ann Intern Med. 2010 Nov 2;153(9):600-6. doi: 10.7326/0003-4819-153-9-201011020-00010.

PMID:
21041580
19.

Opening up to precompetitive collaboration.

Altshuler JS, Balogh E, Barker AD, Eck SL, Friend SH, Ginsburg GS, Herbst RS, Nass SJ, Streeter CM, Wagner JA.

Sci Transl Med. 2010 Oct 6;2(52):52cm26. doi: 10.1126/scitranslmed.3001515.

PMID:
20926831
20.

Perestroika in pharma: evolution or revolution in drug development?

FitzGerald GA.

Mt Sinai J Med. 2010 Jul-Aug;77(4):327-32. doi: 10.1002/msj.20198.

PMID:
20687177

Supplemental Content

Support Center